Medication Description: Letrozole
4,4ґ- (1H-1,2,4-1-yl-methylene) dibenzonitrile.
Synonym: Femara, Femara.
According to the mechanism of action and indications for use is close to anastrozole.
When ingestion is absorbed completely, bioavailability reaches 100%, T Ѕ is about 48 hours; undergoes biotransformation in the liver, excreted mainly by the kidneys.
Assign inside of 0.0025 g (2.5 mg) 1 time per day for a long time (5-10 years or more).
Possible side effects: dyspeptic symptoms, weakness, headache, gynecological bleeding, peripheral edema, myalgia, hot flashes, thinning hair, rash.
Contraindications: premenstrual syndrome, pronounced renal dysfunction, pregnancy, breastfeeding.
Product form: tablets of 0.0025 g (2.5 mg) (N. 30).
Storage: List B.